GlassScriptPhysician profile
Julia Nemiroff
NPI 1497018006
$3,480.46
in general payments reported to CMS, 2019-2025
26 companies · $1,233 in 2025
The $1,233 reported for 2025 was more than what 78% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $30.03 · 2021: $133 · 2022: $398 · 2023: $268 · 2024: $1,222 · 2025: $1,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,723.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $536.11 | 2019-2025 | Vabysmo, Susvimo |
| Apellis Pharmaceuticals, INC. | $385.32 | 2024-2025 | Syfovre |
| Abbvie INC. | $324.38 | 2022-2025 | |
| Alimera Sciences, INC. | $282.51 | 2022-2024 | Iluvien, Yutiq |
| New World Medical,INC. | $251.41 | 2024 | Streamline, Kahook Dual Blade, Clearpath |
| Regeneron Healthcare Solutions, INC. | $208.93 | 2019-2025 | Eylea Hd, Eylea |
| Tarsus Pharmaceuticals, INC. | $180.97 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $180.74 | 2019-2025 | Constellation, Clareon, Clareon Panoptix Pro |
| Mallinckrodt Hospital Products INC. | $179.46 | 2025 | Acthar |
| Bausch & Lomb Americas INC. | $169.58 | 2022-2025 | Infuse |
| Beaver-Visitec International, INC. | $146.45 | 2022 | |
| Ani Pharmaceuticals, INC. | $102.11 | 2024-2025 | Purified Cortrophin Gel |
| Dompe US, INC. | $73.88 | 2024-2025 | Oxervate |
| Astellas Pharma US INC | $72.90 | 2023-2025 | Izervay |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $60.39 | 2021 | |
| Merz North America, INC. | $49.20 | 2021 | |
| Ocular Therapeutix, INC. | $40.51 | 2023-2024 | Dextenza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $30.03 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $27.04 | 2023 | Acuvue |
| Oyster Point Pharma, INC. | $24.65 | 2022 | |
| Aerie Pharmaceuticals, INC. | $19.26 | 2019 | |
| Sight Sciences, INC. | $18.21 | 2023 | Tearcare System |
| Rxsight INC | $17.96 | 2024 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Coopervision INC. | $17.53 | 2023 | Myday Contact Lens |
| Amgen INC. | $16.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Nemiroff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.